Why Testosterone Cypionate Causes Injection-Site Pain: The Mechanism Explained
At a glance
- Label reaction / Inflammation and pain at the intramuscular injection site are listed adverse reactions of Depo-Testosterone, with no frequency given [1]
- Formulation / Each mL of the 200 mg/mL strength contains 200 mg testosterone cypionate, 0.2 mL benzyl benzoate, 560 mg cottonseed oil and 9.45 mg benzyl alcohol [1]
- Route / The Depo-Testosterone label specifies deep gluteal intramuscular injection and says the product should not be given intravenously [1]
- Depot / The ester is absorbed slowly from the oil in the muscle, with a half-life of about 8 days [1]
- Enanthate data / 162 of 551 weekly enanthate-in-castor-oil injections caused minor local effects, mostly pain and bleeding [2]
- Subcutaneous data / 9 of 63 patients on weekly subcutaneous testosterone had minor, transient local reactions [3]
- Infection signs / Expanding redness, warmth, fever or drainage can be signs of cellulitis [4]
The label lists the reaction but not a mechanism
The Depo-Testosterone prescribing information describes testosterone cypionate as the oil-soluble cyclopentylpropionate ester of testosterone, insoluble in water and soluble in vegetable oils [1]. Each mL of the 100 mg/mL solution contains 100 mg testosterone cypionate, 0.1 mL benzyl benzoate, 736 mg cottonseed oil and 9.45 mg benzyl alcohol; each mL of the 200 mg/mL strength contains 200 mg, 0.2 mL, 560 mg and 9.45 mg of those inactive ingredients [1].
The adverse reactions section lists inflammation and pain at the site of intramuscular injection as a miscellaneous reaction, with no frequency given [1]. The label gives the injection as 50 to 400 mg every two to four weeks, deep in the gluteal muscle, and states the product is for intramuscular use only and should not be given intravenously [1]. It names the route, the depth and the ingredients, but not any one of them as the cause of pain [1].
Slow release is the point of the oil
The label explains the pharmacokinetics: testosterone esters in oil injected intramuscularly are absorbed slowly from the lipid phase, which is why testosterone cypionate can be given at intervals of two to four weeks, and the half-life after an intramuscular injection is about eight days [1]. The label does not say that this slow absorption itself causes injection-site pain [1].
Pain and bleeding at the injection site
Pain and bleeding were the most common minor local effects in a prospective survey of weekly deep intramuscular testosterone enanthate injections in castor oil [2]. In that survey the gluteal site produced fewer complaints overall and less bleeding than the deltoid or thigh, but was painful more often than either [2].
Allergy is possible and hard to pin on the oil
The label lists hypersensitivity, including skin manifestations, and anaphylactoid reactions among the allergic reactions reported with androgens, and known hypersensitivity to the drug is a contraindication [1]. A 2024 case report in Contact Dermatitis described a delayed hypersensitivity reaction to testosterone cypionate injections [5]. A single case establishes that the pattern exists, not how often it occurs.
One injection exposes a person to the testosterone ester, cottonseed oil, benzyl benzoate and benzyl alcohol [1], and the label does not say which component causes a reaction in a given person.
Infection is a different diagnosis
Cellulitis is a common skin infection caused by bacteria that affects the middle layer of the skin and the tissues below. MedlinePlus describes redness or inflammation that gets bigger as the infection spreads, warm skin, tenderness, and fever with chills and sweating, with drainage where an abscess has formed, and notes that a clinician may mark the edge of the redness to see whether it crosses the line over the next few days [4].
What the published numbers show
In the survey of testosterone enanthate in castor oil, 26 men received 551 weekly deep intramuscular injections, assessed immediately and one week later by the same nurse using a standard questionnaire. Of the 551 injections, 389 (70.6%) produced no complaint and 162 (29.4%) produced minor local effects, mostly pain and bleeding; no serious side effects occurred [2]. That result does not give a rate for testosterone cypionate.
Subcutaneous injection and reported pain
Three small studies in transgender patients looked at subcutaneous testosterone. In a retrospective cohort of 63 female-to-male transgender patients on weekly subcutaneous testosterone cypionate or enanthate, minor and transient local reactions were reported in 9 of 63, and all 22 who switched from intramuscular injections preferred the subcutaneous route [3]. In a 14-person crossover pilot, total testosterone exposure was comparable between routes, and subcutaneous injections scored lower for pre-injection anxiety, pain during injection and post-injection pain, with wide individual variability [6]. In 11 patients on weekly subcutaneous cypionate, total and free testosterone stayed stable between injections and no adverse effects were reported [7].
The Depo-Testosterone label specifies the intramuscular route only [1].
Does the carrier oil matter?
The label does not rank its ingredients by irritancy [1]. The pain-and-bleeding figures above come from a castor oil product [2].
Frequently asked questions
Why does testosterone cypionate hurt after the injection?
Is the cottonseed oil the cause of the pain?
How common is injection-site pain with testosterone cypionate?
Is a late itchy rash an allergy?
Can subcutaneous injections reduce the pain?
What are signs of infection at the site?
References
- U.S. National Library of Medicine, DailyMed. Depo-Testosterone (cypionate) intramuscular, Pharmacia & Upjohn/Pfizer (testosterone cypionate) prescribing information. Depo-Testosterone (cypionate) intramuscular, Pharmacia & Upjohn/Pfizer (testosterone cypionate) label
- Mackey MA, Conway AJ, Handelsman DJ. Tolerability of intramuscular injections of testosterone ester in oil vehicle. Hum Reprod. 1995;10(4):862-5. Tolerability of intramuscular injections of testosterone ester in oil vehicle
- Spratt DI, Stewart II, Savage C, Craig W, Spack NP, Chandler DW, et al. Subcutaneous Injection of Testosterone Is an Effective and Preferred Alternative to Intramuscular Injection: Demonstration in Female-to-Male Transgender Patients. J Clin Endocrinol Metab. 2017;102(7):2349-2355. Subcutaneous Injection of Testosterone Is an Effective and Preferred Alternative to Intramuscular Injection: Demonstration in Female-to-Male Transgender Patients
- Cellulitis: MedlinePlus Medical Encyclopedia. Cellulitis: MedlinePlus Medical Encyclopedia
- Ponce MB, Schauberger E, Connor E, Reeder M. Delayed hypersensitivity reaction to testosterone cypionate injections. Contact Dermatitis. 2024;91(4):364-365. Delayed hypersensitivity reaction to testosterone cypionate injections
- Wilson DM, Kiang TKL, Ensom MHH. Pharmacokinetics, safety, and patient acceptability of subcutaneous versus intramuscular testosterone injection for gender-affirming therapy: A pilot study. Am J Health Syst Pharm. 2018;75(6):351-358. Pharmacokinetics, safety, and patient acceptability of subcutaneous versus intramuscular testosterone injection for gender-affirming therapy: A pilot study
- McFarland J, Craig W, Clarke NJ, Spratt DI. Serum Testosterone Concentrations Remain Stable Between Injections in Patients Receiving Subcutaneous Testosterone. J Endocr Soc. 2017;1(8):1095-1103. Serum Testosterone Concentrations Remain Stable Between Injections in Patients Receiving Subcutaneous Testosterone